nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—SLC22A6—Doxycycline—malaria	0.115	0.188	CbGbCtD
Etodolac—PTGS2—Dapsone—malaria	0.0799	0.131	CbGbCtD
Etodolac—CYP2C9—Pyrimethamine—malaria	0.0696	0.114	CbGbCtD
Etodolac—CYP2C9—Sulfadiazine—malaria	0.0696	0.114	CbGbCtD
Etodolac—PTGS1—Dapsone—malaria	0.0675	0.111	CbGbCtD
Etodolac—CYP2C9—Artemether—malaria	0.0592	0.0969	CbGbCtD
Etodolac—CYP2C9—Proguanil—malaria	0.0556	0.0911	CbGbCtD
Etodolac—CYP2C9—Quinine—malaria	0.0358	0.0587	CbGbCtD
Etodolac—CYP2C9—Quinidine—malaria	0.0315	0.0516	CbGbCtD
Etodolac—CYP2C9—Dapsone—malaria	0.0272	0.0445	CbGbCtD
Etodolac—UGT1A10—kidney—malaria	0.00673	0.0922	CbGeAlD
Etodolac—UGT1A10—digestive system—malaria	0.00571	0.0783	CbGeAlD
Etodolac—UGT1A10—liver—malaria	0.00425	0.0583	CbGeAlD
Etodolac—UGT1A3—digestive system—malaria	0.00402	0.0551	CbGeAlD
Etodolac—RXRA—kidney—malaria	0.00401	0.055	CbGeAlD
Etodolac—UGT1A9—kidney—malaria	0.00338	0.0463	CbGeAlD
Etodolac—UGT1A3—liver—malaria	0.003	0.0411	CbGeAlD
Etodolac—UGT1A9—digestive system—malaria	0.00287	0.0393	CbGeAlD
Etodolac—UGT2B7—kidney—malaria	0.00272	0.0373	CbGeAlD
Etodolac—RXRA—liver—malaria	0.00254	0.0348	CbGeAlD
Etodolac—UGT2B7—digestive system—malaria	0.00231	0.0317	CbGeAlD
Etodolac—PTGS1—endothelium—malaria	0.00221	0.0303	CbGeAlD
Etodolac—CYP2C9—blood plasma—malaria	0.00215	0.0294	CbGeAlD
Etodolac—UGT1A9—liver—malaria	0.00214	0.0293	CbGeAlD
Etodolac—PTGS2—endothelium—malaria	0.00211	0.0289	CbGeAlD
Etodolac—RXRA—brain—malaria	0.00201	0.0276	CbGeAlD
Etodolac—PTGS1—blood plasma—malaria	0.00196	0.0269	CbGeAlD
Etodolac—PTGS2—blood plasma—malaria	0.00187	0.0257	CbGeAlD
Etodolac—UGT2B7—liver—malaria	0.00172	0.0236	CbGeAlD
Etodolac—SLC22A6—brain—malaria	0.00125	0.0172	CbGeAlD
Etodolac—CYP2C9—hematopoietic system—malaria	0.00119	0.0163	CbGeAlD
Etodolac—PTGS1—hematopoietic system—malaria	0.00108	0.0149	CbGeAlD
Etodolac—PTGS2—hematopoietic system—malaria	0.00104	0.0142	CbGeAlD
Etodolac—ALB—liver—malaria	0.000985	0.0135	CbGeAlD
Etodolac—PTGS1—kidney—malaria	0.000888	0.0122	CbGeAlD
Etodolac—PTGS2—kidney—malaria	0.000849	0.0116	CbGeAlD
Etodolac—CYP2C9—digestive system—malaria	0.000826	0.0113	CbGeAlD
Etodolac—CYP2C9—blood—malaria	0.000787	0.0108	CbGeAlD
Etodolac—ALB—brain—malaria	0.000782	0.0107	CbGeAlD
Etodolac—PTGS1—digestive system—malaria	0.000754	0.0103	CbGeAlD
Etodolac—PTGS2—digestive system—malaria	0.00072	0.00988	CbGeAlD
Etodolac—PTGS1—blood—malaria	0.000718	0.00984	CbGeAlD
Etodolac—PTGS2—blood—malaria	0.000686	0.00941	CbGeAlD
Etodolac—PTGS2—bone marrow—malaria	0.000664	0.0091	CbGeAlD
Etodolac—CYP2C9—liver—malaria	0.000615	0.00843	CbGeAlD
Etodolac—PTGS2—liver—malaria	0.000537	0.00736	CbGeAlD
Etodolac—PTGS1—Arachidonic acid metabolism—HPGDS—malaria	0.000511	0.0112	CbGpPWpGaD
Etodolac—UGT1A3—NRF2 pathway—G6PD—malaria	0.000505	0.0111	CbGpPWpGaD
Etodolac—UGT2B7—Phase II conjugation—HPGDS—malaria	0.000491	0.0108	CbGpPWpGaD
Etodolac—Thrombocytopenia—Sulfadiazine—malaria	0.000481	0.00177	CcSEcCtD
Etodolac—Flushing—Clindamycin—malaria	0.000478	0.00176	CcSEcCtD
Etodolac—Erythema multiforme—Quinine—malaria	0.000477	0.00176	CcSEcCtD
Etodolac—Erythema multiforme—Quinidine—malaria	0.000477	0.00176	CcSEcCtD
Etodolac—Agranulocytosis—Quinidine barbiturate—malaria	0.000474	0.00175	CcSEcCtD
Etodolac—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—DECR1—malaria	0.000472	0.0104	CbGpPWpGaD
Etodolac—Tinnitus—Quinidine—malaria	0.000471	0.00174	CcSEcCtD
Etodolac—Tinnitus—Quinine—malaria	0.000471	0.00174	CcSEcCtD
Etodolac—Vomiting—Proguanil—malaria	0.00047	0.00174	CcSEcCtD
Etodolac—Flushing—Quinidine—malaria	0.000469	0.00173	CcSEcCtD
Etodolac—Flushing—Quinine—malaria	0.000469	0.00173	CcSEcCtD
Etodolac—Anorexia—Sulfadiazine—malaria	0.000468	0.00173	CcSEcCtD
Etodolac—RXRA—Vitamin A and Carotenoid Metabolism—CD36—malaria	0.000468	0.0103	CbGpPWpGaD
Etodolac—Rash—Proguanil—malaria	0.000466	0.00172	CcSEcCtD
Etodolac—Dermatitis—Proguanil—malaria	0.000466	0.00172	CcSEcCtD
Etodolac—Headache—Proguanil—malaria	0.000463	0.00171	CcSEcCtD
Etodolac—Haemoglobin—Quinidine barbiturate—malaria	0.000458	0.00169	CcSEcCtD
Etodolac—PTGS2—Overview of nanoparticle effects—CRP—malaria	0.000457	0.0101	CbGpPWpGaD
Etodolac—Haemoglobin—Pentoxifylline—malaria	0.000457	0.00169	CcSEcCtD
Etodolac—Haemorrhage—Quinidine barbiturate—malaria	0.000456	0.00168	CcSEcCtD
Etodolac—Hepatitis—Quinidine barbiturate—malaria	0.000456	0.00168	CcSEcCtD
Etodolac—Haemorrhage—Pentoxifylline—malaria	0.000455	0.00168	CcSEcCtD
Etodolac—Hepatitis—Pentoxifylline—malaria	0.000455	0.00168	CcSEcCtD
Etodolac—ALB—Lipoprotein metabolism—SCARB1—malaria	0.000454	0.00997	CbGpPWpGaD
Etodolac—Hallucination—Quinidine barbiturate—malaria	0.000453	0.00167	CcSEcCtD
Etodolac—Chills—Quinidine—malaria	0.000453	0.00167	CcSEcCtD
Etodolac—Chills—Quinine—malaria	0.000453	0.00167	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000447	0.00165	CcSEcCtD
Etodolac—PTGS1—brain—malaria	0.000446	0.00611	CbGeAlD
Etodolac—Insomnia—Sulfadiazine—malaria	0.000444	0.00164	CcSEcCtD
Etodolac—Flatulence—Clindamycin—malaria	0.000441	0.00163	CcSEcCtD
Etodolac—Nausea—Proguanil—malaria	0.000439	0.00162	CcSEcCtD
Etodolac—Visual impairment—Quinidine barbiturate—malaria	0.000439	0.00162	CcSEcCtD
Etodolac—Dysgeusia—Clindamycin—malaria	0.000439	0.00162	CcSEcCtD
Etodolac—PTGS2—S1P1 pathway—KDR—malaria	0.000438	0.00964	CbGpPWpGaD
Etodolac—Vision blurred—Dapsone—malaria	0.000437	0.00161	CcSEcCtD
Etodolac—ALB—Folate Metabolism—HBB—malaria	0.000434	0.00954	CbGpPWpGaD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000434	0.00954	CbGpPWpGaD
Etodolac—Erythema multiforme—Quinidine barbiturate—malaria	0.000431	0.00159	CcSEcCtD
Etodolac—UGT2B7—NRF2 pathway—G6PD—malaria	0.000429	0.00944	CbGpPWpGaD
Etodolac—Decreased appetite—Sulfadiazine—malaria	0.000427	0.00158	CcSEcCtD
Etodolac—PTGS2—Selenium Micronutrient Network—HBB—malaria	0.000426	0.00937	CbGpPWpGaD
Etodolac—PTGS2—brain—malaria	0.000426	0.00584	CbGeAlD
Etodolac—Tinnitus—Quinidine barbiturate—malaria	0.000425	0.00157	CcSEcCtD
Etodolac—Flushing—Quinidine barbiturate—malaria	0.000423	0.00156	CcSEcCtD
Etodolac—Flushing—Pentoxifylline—malaria	0.000422	0.00156	CcSEcCtD
Etodolac—Vertigo—Dapsone—malaria	0.000416	0.00154	CcSEcCtD
Etodolac—Vision blurred—Quinidine—malaria	0.000414	0.00153	CcSEcCtD
Etodolac—Vision blurred—Quinine—malaria	0.000414	0.00153	CcSEcCtD
Etodolac—Anaemia—Clindamycin—malaria	0.000414	0.00153	CcSEcCtD
Etodolac—Tremor—Quinidine—malaria	0.000412	0.00152	CcSEcCtD
Etodolac—Tremor—Quinine—malaria	0.000412	0.00152	CcSEcCtD
Etodolac—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—DECR1—malaria	0.000411	0.00903	CbGpPWpGaD
Etodolac—Chills—Quinidine barbiturate—malaria	0.000409	0.00151	CcSEcCtD
Etodolac—Arrhythmia—Pentoxifylline—malaria	0.000406	0.0015	CcSEcCtD
Etodolac—PTGS2—Arachidonic acid metabolism—HPGDS—malaria	0.000406	0.00892	CbGpPWpGaD
Etodolac—Vertigo—Clindamycin—malaria	0.000403	0.00149	CcSEcCtD
Etodolac—Angioedema—Quinine—malaria	0.000402	0.00148	CcSEcCtD
Etodolac—Angioedema—Quinidine—malaria	0.000402	0.00148	CcSEcCtD
Etodolac—Gastrointestinal pain—Sulfadiazine—malaria	0.000402	0.00148	CcSEcCtD
Etodolac—Leukopenia—Clindamycin—malaria	0.000401	0.00148	CcSEcCtD
Etodolac—RXRA—NRF2 pathway—G6PD—malaria	0.000401	0.00881	CbGpPWpGaD
Etodolac—UGT1A9—Phase II conjugation—HPGDS—malaria	0.000399	0.00877	CbGpPWpGaD
Etodolac—Vertigo—Quinine—malaria	0.000395	0.00146	CcSEcCtD
Etodolac—Vertigo—Quinidine—malaria	0.000395	0.00146	CcSEcCtD
Etodolac—Syncope—Quinidine—malaria	0.000394	0.00146	CcSEcCtD
Etodolac—Syncope—Quinine—malaria	0.000394	0.00146	CcSEcCtD
Etodolac—Leukopenia—Quinidine—malaria	0.000393	0.00145	CcSEcCtD
Etodolac—Leukopenia—Quinine—malaria	0.000393	0.00145	CcSEcCtD
Etodolac—Flatulence—Pentoxifylline—malaria	0.00039	0.00144	CcSEcCtD
Etodolac—Urticaria—Sulfadiazine—malaria	0.00039	0.00144	CcSEcCtD
Etodolac—Tension—Quinidine barbiturate—malaria	0.000389	0.00144	CcSEcCtD
Etodolac—Tension—Pentoxifylline—malaria	0.000389	0.00143	CcSEcCtD
Etodolac—Palpitations—Quinidine—malaria	0.000388	0.00143	CcSEcCtD
Etodolac—Palpitations—Quinine—malaria	0.000388	0.00143	CcSEcCtD
Etodolac—Abdominal pain—Sulfadiazine—malaria	0.000388	0.00143	CcSEcCtD
Etodolac—Body temperature increased—Sulfadiazine—malaria	0.000388	0.00143	CcSEcCtD
Etodolac—Dysgeusia—Pentoxifylline—malaria	0.000388	0.00143	CcSEcCtD
Etodolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—malaria	0.000388	0.00852	CbGpPWpGaD
Etodolac—Hypertension—Clindamycin—malaria	0.000387	0.00143	CcSEcCtD
Etodolac—Loss of consciousness—Quinidine—malaria	0.000386	0.00143	CcSEcCtD
Etodolac—Loss of consciousness—Quinine—malaria	0.000386	0.00143	CcSEcCtD
Etodolac—Nervousness—Quinidine barbiturate—malaria	0.000385	0.00142	CcSEcCtD
Etodolac—Nervousness—Pentoxifylline—malaria	0.000385	0.00142	CcSEcCtD
Etodolac—Convulsion—Quinidine—malaria	0.000381	0.00141	CcSEcCtD
Etodolac—Convulsion—Quinine—malaria	0.000381	0.00141	CcSEcCtD
Etodolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—malaria	0.000377	0.00829	CbGpPWpGaD
Etodolac—Discomfort—Clindamycin—malaria	0.000377	0.00139	CcSEcCtD
Etodolac—Myalgia—Quinidine—malaria	0.000374	0.00138	CcSEcCtD
Etodolac—Myalgia—Quinine—malaria	0.000374	0.00138	CcSEcCtD
Etodolac—Vision blurred—Quinidine barbiturate—malaria	0.000374	0.00138	CcSEcCtD
Etodolac—Vision blurred—Pentoxifylline—malaria	0.000373	0.00138	CcSEcCtD
Etodolac—Tremor—Quinidine barbiturate—malaria	0.000372	0.00137	CcSEcCtD
Etodolac—Tremor—Pentoxifylline—malaria	0.000371	0.00137	CcSEcCtD
Etodolac—Tachycardia—Dapsone—malaria	0.000369	0.00136	CcSEcCtD
Etodolac—Ill-defined disorder—Pentoxifylline—malaria	0.000367	0.00136	CcSEcCtD
Etodolac—Anaemia—Pentoxifylline—malaria	0.000366	0.00135	CcSEcCtD
Etodolac—Anaphylactic shock—Clindamycin—malaria	0.000366	0.00135	CcSEcCtD
Etodolac—Angioedema—Quinidine barbiturate—malaria	0.000362	0.00134	CcSEcCtD
Etodolac—Angioedema—Pentoxifylline—malaria	0.000362	0.00134	CcSEcCtD
Etodolac—Hypersensitivity—Sulfadiazine—malaria	0.000362	0.00134	CcSEcCtD
Etodolac—Confusional state—Quinine—malaria	0.000362	0.00134	CcSEcCtD
Etodolac—Confusional state—Quinidine—malaria	0.000362	0.00134	CcSEcCtD
Etodolac—Oedema—Quinidine—malaria	0.000359	0.00132	CcSEcCtD
Etodolac—Oedema—Quinine—malaria	0.000359	0.00132	CcSEcCtD
Etodolac—Thrombocytopenia—Clindamycin—malaria	0.000358	0.00132	CcSEcCtD
Etodolac—Malaise—Pentoxifylline—malaria	0.000357	0.00132	CcSEcCtD
Etodolac—Vertigo—Quinidine barbiturate—malaria	0.000356	0.00132	CcSEcCtD
Etodolac—Syncope—Quinidine barbiturate—malaria	0.000356	0.00131	CcSEcCtD
Etodolac—Leukopenia—Quinidine barbiturate—malaria	0.000355	0.00131	CcSEcCtD
Etodolac—Leukopenia—Pentoxifylline—malaria	0.000354	0.00131	CcSEcCtD
Etodolac—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SCARB1—malaria	0.000353	0.00777	CbGpPWpGaD
Etodolac—Shock—Quinidine—malaria	0.000353	0.0013	CcSEcCtD
Etodolac—Shock—Quinine—malaria	0.000353	0.0013	CcSEcCtD
Etodolac—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	0.000353	0.00775	CbGpPWpGaD
Etodolac—Thrombocytopenia—Quinine—malaria	0.000351	0.0013	CcSEcCtD
Etodolac—Thrombocytopenia—Quinidine—malaria	0.000351	0.0013	CcSEcCtD
Etodolac—Palpitations—Quinidine barbiturate—malaria	0.000351	0.00129	CcSEcCtD
Etodolac—Tachycardia—Quinine—malaria	0.00035	0.00129	CcSEcCtD
Etodolac—Tachycardia—Quinidine—malaria	0.00035	0.00129	CcSEcCtD
Etodolac—Palpitations—Pentoxifylline—malaria	0.00035	0.00129	CcSEcCtD
Etodolac—UGT1A9—NRF2 pathway—G6PD—malaria	0.000349	0.00767	CbGpPWpGaD
Etodolac—Loss of consciousness—Quinidine barbiturate—malaria	0.000349	0.00129	CcSEcCtD
Etodolac—Pruritus—Sulfadiazine—malaria	0.000347	0.00128	CcSEcCtD
Etodolac—Hyperhidrosis—Quinine—malaria	0.000347	0.00128	CcSEcCtD
Etodolac—Hyperhidrosis—Quinidine—malaria	0.000347	0.00128	CcSEcCtD
Etodolac—ALB—Selenium Micronutrient Network—HBB—malaria	0.000345	0.00758	CbGpPWpGaD
Etodolac—Convulsion—Quinidine barbiturate—malaria	0.000344	0.00127	CcSEcCtD
Etodolac—Convulsion—Pentoxifylline—malaria	0.000343	0.00127	CcSEcCtD
Etodolac—Anorexia—Quinidine—malaria	0.000342	0.00126	CcSEcCtD
Etodolac—Anorexia—Quinine—malaria	0.000342	0.00126	CcSEcCtD
Etodolac—Insomnia—Dapsone—malaria	0.000342	0.00126	CcSEcCtD
Etodolac—Hypertension—Pentoxifylline—malaria	0.000342	0.00126	CcSEcCtD
Etodolac—Hypotension—Clindamycin—malaria	0.000342	0.00126	CcSEcCtD
Etodolac—UGT1A3—Biological oxidations—HPGDS—malaria	0.000338	0.00743	CbGpPWpGaD
Etodolac—Arthralgia—Quinidine barbiturate—malaria	0.000338	0.00125	CcSEcCtD
Etodolac—Myalgia—Quinidine barbiturate—malaria	0.000338	0.00125	CcSEcCtD
Etodolac—Myalgia—Pentoxifylline—malaria	0.000337	0.00124	CcSEcCtD
Etodolac—Anxiety—Quinidine barbiturate—malaria	0.000337	0.00124	CcSEcCtD
Etodolac—Diarrhoea—Sulfadiazine—malaria	0.000336	0.00124	CcSEcCtD
Etodolac—Anxiety—Pentoxifylline—malaria	0.000336	0.00124	CcSEcCtD
Etodolac—Hypotension—Quinidine—malaria	0.000335	0.00124	CcSEcCtD
Etodolac—Hypotension—Quinine—malaria	0.000335	0.00124	CcSEcCtD
Etodolac—Discomfort—Pentoxifylline—malaria	0.000333	0.00123	CcSEcCtD
Etodolac—Dry mouth—Pentoxifylline—malaria	0.00033	0.00122	CcSEcCtD
Etodolac—SLC22A6—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000328	0.00721	CbGpPWpGaD
Etodolac—Musculoskeletal discomfort—Quinidine—malaria	0.000327	0.00121	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Quinine—malaria	0.000327	0.00121	CcSEcCtD
Etodolac—RXRA—Transcription factor regulation in adipogenesis—TNF—malaria	0.000327	0.00718	CbGpPWpGaD
Etodolac—Confusional state—Quinidine barbiturate—malaria	0.000326	0.00121	CcSEcCtD
Etodolac—Dyspnoea—Clindamycin—malaria	0.000326	0.0012	CcSEcCtD
Etodolac—Confusional state—Pentoxifylline—malaria	0.000326	0.0012	CcSEcCtD
Etodolac—Oedema—Quinidine barbiturate—malaria	0.000324	0.0012	CcSEcCtD
Etodolac—Anaphylactic shock—Pentoxifylline—malaria	0.000323	0.00119	CcSEcCtD
Etodolac—Oedema—Pentoxifylline—malaria	0.000323	0.00119	CcSEcCtD
Etodolac—Dyspepsia—Clindamycin—malaria	0.000322	0.00119	CcSEcCtD
Etodolac—Infection—Pentoxifylline—malaria	0.000321	0.00119	CcSEcCtD
Etodolac—Dyspnoea—Quinine—malaria	0.00032	0.00118	CcSEcCtD
Etodolac—Dyspnoea—Quinidine—malaria	0.00032	0.00118	CcSEcCtD
Etodolac—Shock—Quinidine barbiturate—malaria	0.000319	0.00118	CcSEcCtD
Etodolac—Shock—Pentoxifylline—malaria	0.000318	0.00117	CcSEcCtD
Etodolac—Thrombocytopenia—Quinidine barbiturate—malaria	0.000317	0.00117	CcSEcCtD
Etodolac—Thrombocytopenia—Pentoxifylline—malaria	0.000316	0.00117	CcSEcCtD
Etodolac—Tachycardia—Quinidine barbiturate—malaria	0.000316	0.00117	CcSEcCtD
Etodolac—Tachycardia—Pentoxifylline—malaria	0.000315	0.00116	CcSEcCtD
Etodolac—Fatigue—Clindamycin—malaria	0.000315	0.00116	CcSEcCtD
Etodolac—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	0.000314	0.00691	CbGpPWpGaD
Etodolac—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	0.000313	0.00689	CbGpPWpGaD
Etodolac—Hyperhidrosis—Quinidine barbiturate—malaria	0.000313	0.00116	CcSEcCtD
Etodolac—Pain—Clindamycin—malaria	0.000313	0.00115	CcSEcCtD
Etodolac—Constipation—Clindamycin—malaria	0.000313	0.00115	CcSEcCtD
Etodolac—Hyperhidrosis—Pentoxifylline—malaria	0.000312	0.00115	CcSEcCtD
Etodolac—Vomiting—Sulfadiazine—malaria	0.000312	0.00115	CcSEcCtD
Etodolac—Decreased appetite—Quinidine—malaria	0.000312	0.00115	CcSEcCtD
Etodolac—Decreased appetite—Quinine—malaria	0.000312	0.00115	CcSEcCtD
Etodolac—Rash—Sulfadiazine—malaria	0.00031	0.00114	CcSEcCtD
Etodolac—Dermatitis—Sulfadiazine—malaria	0.000309	0.00114	CcSEcCtD
Etodolac—Gastrointestinal pain—Dapsone—malaria	0.000309	0.00114	CcSEcCtD
Etodolac—Anorexia—Quinidine barbiturate—malaria	0.000309	0.00114	CcSEcCtD
Etodolac—Anorexia—Pentoxifylline—malaria	0.000308	0.00114	CcSEcCtD
Etodolac—Headache—Sulfadiazine—malaria	0.000308	0.00114	CcSEcCtD
Etodolac—Hypotension—Quinidine barbiturate—malaria	0.000303	0.00112	CcSEcCtD
Etodolac—Hypotension—Pentoxifylline—malaria	0.000302	0.00111	CcSEcCtD
Etodolac—ALB—Lipid and lipoprotein metabolism—SCARB1—malaria	0.000302	0.00663	CbGpPWpGaD
Etodolac—Gastrointestinal pain—Clindamycin—malaria	0.000299	0.0011	CcSEcCtD
Etodolac—Abdominal pain—Dapsone—malaria	0.000299	0.0011	CcSEcCtD
Etodolac—Body temperature increased—Dapsone—malaria	0.000299	0.0011	CcSEcCtD
Etodolac—PTGS1—Selenium Micronutrient Network—SCARB1—malaria	0.000299	0.00657	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—SCARB1—malaria	0.000297	0.00652	CbGpPWpGaD
Etodolac—Feeling abnormal—Quinidine—malaria	0.000296	0.00109	CcSEcCtD
Etodolac—Feeling abnormal—Quinine—malaria	0.000296	0.00109	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000295	0.00109	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000294	0.00109	CcSEcCtD
Etodolac—RXRA—Transcriptional regulation of white adipocyte differentiation—CD36—malaria	0.000294	0.00646	CbGpPWpGaD
Etodolac—Gastrointestinal pain—Quinidine—malaria	0.000293	0.00108	CcSEcCtD
Etodolac—Gastrointestinal pain—Quinine—malaria	0.000293	0.00108	CcSEcCtD
Etodolac—Insomnia—Pentoxifylline—malaria	0.000292	0.00108	CcSEcCtD
Etodolac—Nausea—Sulfadiazine—malaria	0.000292	0.00108	CcSEcCtD
Etodolac—Urticaria—Clindamycin—malaria	0.00029	0.00107	CcSEcCtD
Etodolac—Abdominal pain—Clindamycin—malaria	0.000289	0.00107	CcSEcCtD
Etodolac—Body temperature increased—Clindamycin—malaria	0.000289	0.00107	CcSEcCtD
Etodolac—Dyspnoea—Quinidine barbiturate—malaria	0.000289	0.00107	CcSEcCtD
Etodolac—Dyspnoea—Pentoxifylline—malaria	0.000288	0.00106	CcSEcCtD
Etodolac—Somnolence—Quinidine barbiturate—malaria	0.000288	0.00106	CcSEcCtD
Etodolac—Somnolence—Pentoxifylline—malaria	0.000287	0.00106	CcSEcCtD
Etodolac—UGT2B7—Biological oxidations—HPGDS—malaria	0.000287	0.00632	CbGpPWpGaD
Etodolac—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—malaria	0.000286	0.00628	CbGpPWpGaD
Etodolac—Urticaria—Quinidine—malaria	0.000285	0.00105	CcSEcCtD
Etodolac—Urticaria—Quinine—malaria	0.000285	0.00105	CcSEcCtD
Etodolac—Dyspepsia—Pentoxifylline—malaria	0.000284	0.00105	CcSEcCtD
Etodolac—Body temperature increased—Quinidine—malaria	0.000284	0.00105	CcSEcCtD
Etodolac—Abdominal pain—Quinidine—malaria	0.000284	0.00105	CcSEcCtD
Etodolac—Abdominal pain—Quinine—malaria	0.000284	0.00105	CcSEcCtD
Etodolac—Body temperature increased—Quinine—malaria	0.000284	0.00105	CcSEcCtD
Etodolac—Decreased appetite—Quinidine barbiturate—malaria	0.000281	0.00104	CcSEcCtD
Etodolac—Decreased appetite—Pentoxifylline—malaria	0.000281	0.00104	CcSEcCtD
Etodolac—Pain—Quinidine barbiturate—malaria	0.000277	0.00102	CcSEcCtD
Etodolac—Constipation—Quinidine barbiturate—malaria	0.000277	0.00102	CcSEcCtD
Etodolac—Constipation—Pentoxifylline—malaria	0.000276	0.00102	CcSEcCtD
Etodolac—Hypersensitivity—Clindamycin—malaria	0.000269	0.000995	CcSEcCtD
Etodolac—CYP2C9—Arachidonic acid metabolism—HPGDS—malaria	0.000269	0.00591	CbGpPWpGaD
Etodolac—RXRA—Biological oxidations—HPGDS—malaria	0.000268	0.00589	CbGpPWpGaD
Etodolac—Feeling abnormal—Quinidine barbiturate—malaria	0.000267	0.000985	CcSEcCtD
Etodolac—Feeling abnormal—Pentoxifylline—malaria	0.000266	0.000983	CcSEcCtD
Etodolac—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000265	0.000977	CcSEcCtD
Etodolac—Hypersensitivity—Quinine—malaria	0.000264	0.000976	CcSEcCtD
Etodolac—Hypersensitivity—Quinidine—malaria	0.000264	0.000976	CcSEcCtD
Etodolac—Gastrointestinal pain—Pentoxifylline—malaria	0.000264	0.000976	CcSEcCtD
Etodolac—RXRA—Transcription factor regulation in adipogenesis—IL6—malaria	0.000263	0.00579	CbGpPWpGaD
Etodolac—Asthenia—Clindamycin—malaria	0.000262	0.000969	CcSEcCtD
Etodolac—PTGS1—Overview of nanoparticle effects—TNF—malaria	0.000261	0.00573	CbGpPWpGaD
Etodolac—Pruritus—Clindamycin—malaria	0.000259	0.000955	CcSEcCtD
Etodolac—Asthenia—Quinidine—malaria	0.000257	0.00095	CcSEcCtD
Etodolac—Asthenia—Quinine—malaria	0.000257	0.00095	CcSEcCtD
Etodolac—Urticaria—Quinidine barbiturate—malaria	0.000257	0.000949	CcSEcCtD
Etodolac—Urticaria—Pentoxifylline—malaria	0.000257	0.000948	CcSEcCtD
Etodolac—Abdominal pain—Quinidine barbiturate—malaria	0.000256	0.000945	CcSEcCtD
Etodolac—Body temperature increased—Quinidine barbiturate—malaria	0.000256	0.000945	CcSEcCtD
Etodolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—malaria	0.000256	0.00562	CbGpPWpGaD
Etodolac—Abdominal pain—Pentoxifylline—malaria	0.000255	0.000943	CcSEcCtD
Etodolac—Body temperature increased—Pentoxifylline—malaria	0.000255	0.000943	CcSEcCtD
Etodolac—Pruritus—Quinine—malaria	0.000254	0.000937	CcSEcCtD
Etodolac—Pruritus—Quinidine—malaria	0.000254	0.000937	CcSEcCtD
Etodolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—malaria	0.000251	0.00551	CbGpPWpGaD
Etodolac—Diarrhoea—Clindamycin—malaria	0.00025	0.000924	CcSEcCtD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—CD36—malaria	0.00025	0.0055	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000246	0.00542	CbGpPWpGaD
Etodolac—Diarrhoea—Quinine—malaria	0.000245	0.000906	CcSEcCtD
Etodolac—Diarrhoea—Quinidine—malaria	0.000245	0.000906	CcSEcCtD
Etodolac—ALB—Folate Metabolism—DHFR—malaria	0.000244	0.00536	CbGpPWpGaD
Etodolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—malaria	0.000244	0.00536	CbGpPWpGaD
Etodolac—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	0.000244	0.00536	CbGpPWpGaD
Etodolac—Dizziness—Clindamycin—malaria	0.000242	0.000893	CcSEcCtD
Etodolac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—malaria	0.000242	0.00532	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—SCARB1—malaria	0.000241	0.00531	CbGpPWpGaD
Etodolac—Vomiting—Dapsone—malaria	0.00024	0.000887	CcSEcCtD
Etodolac—Hypersensitivity—Quinidine barbiturate—malaria	0.000239	0.000881	CcSEcCtD
Etodolac—Hypersensitivity—Pentoxifylline—malaria	0.000238	0.000879	CcSEcCtD
Etodolac—Dizziness—Quinidine—malaria	0.000237	0.000876	CcSEcCtD
Etodolac—Dizziness—Quinine—malaria	0.000237	0.000876	CcSEcCtD
Etodolac—PTGS2—Selenium Micronutrient Network—SCARB1—malaria	0.000237	0.00521	CbGpPWpGaD
Etodolac—Headache—Dapsone—malaria	0.000237	0.000874	CcSEcCtD
Etodolac—UGT1A9—Biological oxidations—HPGDS—malaria	0.000233	0.00513	CbGpPWpGaD
Etodolac—Vomiting—Clindamycin—malaria	0.000232	0.000858	CcSEcCtD
Etodolac—Asthenia—Quinidine barbiturate—malaria	0.000232	0.000858	CcSEcCtD
Etodolac—Asthenia—Pentoxifylline—malaria	0.000232	0.000856	CcSEcCtD
Etodolac—Rash—Clindamycin—malaria	0.000231	0.000851	CcSEcCtD
Etodolac—Dermatitis—Clindamycin—malaria	0.00023	0.00085	CcSEcCtD
Etodolac—Headache—Clindamycin—malaria	0.000229	0.000846	CcSEcCtD
Etodolac—Pruritus—Quinidine barbiturate—malaria	0.000229	0.000846	CcSEcCtD
Etodolac—Pruritus—Pentoxifylline—malaria	0.000229	0.000844	CcSEcCtD
Etodolac—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	0.000228	0.00502	CbGpPWpGaD
Etodolac—Vomiting—Quinidine—malaria	0.000228	0.000842	CcSEcCtD
Etodolac—Vomiting—Quinine—malaria	0.000228	0.000842	CcSEcCtD
Etodolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—malaria	0.000228	0.00501	CbGpPWpGaD
Etodolac—Rash—Quinine—malaria	0.000226	0.000835	CcSEcCtD
Etodolac—Rash—Quinidine—malaria	0.000226	0.000835	CcSEcCtD
Etodolac—Dermatitis—Quinine—malaria	0.000226	0.000834	CcSEcCtD
Etodolac—Dermatitis—Quinidine—malaria	0.000226	0.000834	CcSEcCtD
Etodolac—Headache—Quinidine—malaria	0.000225	0.00083	CcSEcCtD
Etodolac—Headache—Quinine—malaria	0.000225	0.00083	CcSEcCtD
Etodolac—Nausea—Dapsone—malaria	0.000225	0.000829	CcSEcCtD
Etodolac—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—malaria	0.000222	0.00488	CbGpPWpGaD
Etodolac—Diarrhoea—Quinidine barbiturate—malaria	0.000222	0.000818	CcSEcCtD
Etodolac—Diarrhoea—Pentoxifylline—malaria	0.000221	0.000816	CcSEcCtD
Etodolac—RXRA—PPARA activates gene expression—CD36—malaria	0.000221	0.00485	CbGpPWpGaD
Etodolac—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	0.000217	0.00478	CbGpPWpGaD
Etodolac—Nausea—Clindamycin—malaria	0.000217	0.000802	CcSEcCtD
Etodolac—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	0.000216	0.00476	CbGpPWpGaD
Etodolac—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—malaria	0.000216	0.00475	CbGpPWpGaD
Etodolac—Dizziness—Quinidine barbiturate—malaria	0.000214	0.00079	CcSEcCtD
Etodolac—Dizziness—Pentoxifylline—malaria	0.000214	0.000789	CcSEcCtD
Etodolac—Nausea—Quinine—malaria	0.000213	0.000787	CcSEcCtD
Etodolac—Nausea—Quinidine—malaria	0.000213	0.000787	CcSEcCtD
Etodolac—PTGS1—Overview of nanoparticle effects—IL6—malaria	0.00021	0.00463	CbGpPWpGaD
Etodolac—PTGS2—Overview of nanoparticle effects—TNF—malaria	0.000207	0.00455	CbGpPWpGaD
Etodolac—Vomiting—Quinidine barbiturate—malaria	0.000206	0.00076	CcSEcCtD
Etodolac—Vomiting—Pentoxifylline—malaria	0.000205	0.000759	CcSEcCtD
Etodolac—PTGS2—Spinal Cord Injury—FCGR2A—malaria	0.000204	0.00449	CbGpPWpGaD
Etodolac—Rash—Quinidine barbiturate—malaria	0.000204	0.000754	CcSEcCtD
Etodolac—Dermatitis—Quinidine barbiturate—malaria	0.000204	0.000753	CcSEcCtD
Etodolac—Rash—Pentoxifylline—malaria	0.000204	0.000752	CcSEcCtD
Etodolac—Dermatitis—Pentoxifylline—malaria	0.000204	0.000752	CcSEcCtD
Etodolac—Headache—Quinidine barbiturate—malaria	0.000203	0.000749	CcSEcCtD
Etodolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—malaria	0.000203	0.00445	CbGpPWpGaD
Etodolac—Headache—Pentoxifylline—malaria	0.000202	0.000747	CcSEcCtD
Etodolac—UGT1A9—PPARA activates gene expression—CD36—malaria	0.000192	0.00423	CbGpPWpGaD
Etodolac—Nausea—Quinidine barbiturate—malaria	0.000192	0.00071	CcSEcCtD
Etodolac—Nausea—Pentoxifylline—malaria	0.000192	0.000709	CcSEcCtD
Etodolac—ALB—Selenium Micronutrient Network—SCARB1—malaria	0.000192	0.00422	CbGpPWpGaD
Etodolac—PTGS1—Biological oxidations—HPGDS—malaria	0.00019	0.00418	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—SLC4A1—malaria	0.00019	0.00418	CbGpPWpGaD
Etodolac—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—malaria	0.000188	0.00414	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000188	0.00413	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—FAS—malaria	0.000186	0.00408	CbGpPWpGaD
Etodolac—ALB—SLC-mediated transmembrane transport—SLC4A1—malaria	0.00017	0.00375	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—PKLR—malaria	0.00017	0.00373	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—CRP—malaria	0.000169	0.00371	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—CRP—malaria	0.000168	0.00369	CbGpPWpGaD
Etodolac—PTGS2—Overview of nanoparticle effects—IL6—malaria	0.000167	0.00367	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—SLC4A1—malaria	0.000167	0.00366	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000164	0.0036	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—IL4—malaria	0.000158	0.00347	CbGpPWpGaD
Etodolac—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	0.000158	0.00347	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—ICAM1—malaria	0.000155	0.00341	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—ICAM1—malaria	0.000154	0.00339	CbGpPWpGaD
Etodolac—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—malaria	0.000149	0.00327	CbGpPWpGaD
Etodolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malaria	0.000147	0.00324	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000139	0.00305	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—CRP—malaria	0.000137	0.003	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000136	0.003	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—CRP—malaria	0.000134	0.00295	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000133	0.00293	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—DHODH—malaria	0.000132	0.0029	CbGpPWpGaD
Etodolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malaria	0.000131	0.00288	CbGpPWpGaD
Etodolac—ALB—Platelet degranulation—CD36—malaria	0.00013	0.00286	CbGpPWpGaD
Etodolac—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—malaria	0.00013	0.00285	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—ICAM1—malaria	0.000126	0.00276	CbGpPWpGaD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—CD36—malaria	0.000124	0.00272	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—ICAM1—malaria	0.000123	0.00271	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—IL4—malaria	0.000123	0.0027	CbGpPWpGaD
Etodolac—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—malaria	0.00012	0.00263	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—IFNG—malaria	0.000118	0.0026	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—IFNG—malaria	0.000117	0.00258	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—SLC4A1—malaria	0.000112	0.00247	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—DHODH—malaria	0.000112	0.00247	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—CRP—malaria	0.000109	0.00239	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000106	0.00233	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—DECR1—malaria	0.000105	0.00232	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—IL1B—malaria	0.000105	0.00232	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—IL1B—malaria	0.000105	0.0023	CbGpPWpGaD
Etodolac—RXRA—Metabolism—DHODH—malaria	0.000105	0.0023	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000103	0.00226	CbGpPWpGaD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—TNF—malaria	0.000102	0.00224	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—TLR4—malaria	0.000102	0.00224	CbGpPWpGaD
Etodolac—CYP2C9—Biological oxidations—HPGDS—malaria	0.0001	0.0022	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—ICAM1—malaria	9.97e-05	0.00219	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—ICAM1—malaria	9.75e-05	0.00214	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—NOS2—malaria	9.67e-05	0.00213	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—IFNG—malaria	9.55e-05	0.0021	CbGpPWpGaD
Etodolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malaria	9.54e-05	0.0021	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—HBB—malaria	9.54e-05	0.0021	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—SLC4A1—malaria	9.54e-05	0.0021	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—SCARB1—malaria	9.45e-05	0.00208	CbGpPWpGaD
Etodolac—PTGS2—C-MYB transcription factor network—CD4—malaria	9.4e-05	0.00207	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—IFNG—malaria	9.38e-05	0.00206	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—DHODH—malaria	9.11e-05	0.002	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—DECR1—malaria	8.97e-05	0.00197	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—HPGDS—malaria	8.96e-05	0.00197	CbGpPWpGaD
Etodolac—RXRA—Metabolism—SLC4A1—malaria	8.9e-05	0.00196	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC4A1—malaria	8.66e-05	0.0019	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—DECR1—malaria	8.57e-05	0.00188	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—IL1B—malaria	8.52e-05	0.00187	CbGpPWpGaD
Etodolac—ALB—Hemostasis—HBB—malaria	8.51e-05	0.00187	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PKLR—malaria	8.5e-05	0.00187	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—IL2—malaria	8.49e-05	0.00187	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—IL1B—malaria	8.37e-05	0.00184	CbGpPWpGaD
Etodolac—RXRA—Metabolism—DECR1—malaria	8.36e-05	0.00184	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—SCARB1—malaria	8.23e-05	0.00181	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—HBB—malaria	8.11e-05	0.00178	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—TNF—malaria	7.88e-05	0.00173	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—SLC4A1—malaria	7.75e-05	0.0017	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—malaria	7.69e-05	0.00169	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—TNF—malaria	7.65e-05	0.00168	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—TNF—malaria	7.6e-05	0.00167	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—IFNG—malaria	7.59e-05	0.00167	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—G6PD—malaria	7.58e-05	0.00167	CbGpPWpGaD
Etodolac—RXRA—Metabolism—HBB—malaria	7.56e-05	0.00166	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—DHODH—malaria	7.43e-05	0.00163	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—IFNG—malaria	7.42e-05	0.00163	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—malaria	7.31e-05	0.00161	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—DECR1—malaria	7.29e-05	0.0016	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PKLR—malaria	7.23e-05	0.00159	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—DECR1—malaria	7.01e-05	0.00154	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—IL1B—malaria	6.77e-05	0.00149	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PKLR—malaria	6.74e-05	0.00148	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—malaria	6.71e-05	0.00148	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—CD36—malaria	6.64e-05	0.00146	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—IL1B—malaria	6.62e-05	0.00145	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—IL2—malaria	6.59e-05	0.00145	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—HBB—malaria	6.59e-05	0.00145	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—G6PD—malaria	6.44e-05	0.00142	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—IL6—malaria	6.36e-05	0.0014	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—SLC4A1—malaria	6.32e-05	0.00139	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—TNF—malaria	6.18e-05	0.00136	CbGpPWpGaD
Etodolac—PTGS1—Selenium Micronutrient Network—IL6—malaria	6.17e-05	0.00136	CbGpPWpGaD
Etodolac—ALB—Vitamin B12 Metabolism—IL6—malaria	6.13e-05	0.00135	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—TNF—malaria	6.07e-05	0.00133	CbGpPWpGaD
Etodolac—RXRA—Metabolism—G6PD—malaria	6.01e-05	0.00132	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—DECR1—malaria	5.94e-05	0.00131	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—CD36—malaria	5.93e-05	0.0013	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—DHODH—malaria	5.9e-05	0.0013	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PKLR—malaria	5.87e-05	0.00129	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—malaria	5.8e-05	0.00128	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—TNF—malaria	5.79e-05	0.00127	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—HPGDS—malaria	5.78e-05	0.00127	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—CD36—malaria	5.76e-05	0.00127	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—KDR—malaria	5.74e-05	0.00126	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—HBB—malaria	5.37e-05	0.00118	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—DHFR—malaria	5.36e-05	0.00118	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—malaria	5.33e-05	0.00117	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—SCARB1—malaria	5.3e-05	0.00117	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—G6PD—malaria	5.23e-05	0.00115	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—CD36—malaria	5.17e-05	0.00114	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—SLC4A1—malaria	5.02e-05	0.0011	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—IL6—malaria	4.99e-05	0.0011	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—HPGDS—malaria	4.91e-05	0.00108	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—TNF—malaria	4.91e-05	0.00108	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—IL6—malaria	4.9e-05	0.00108	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—TNF—malaria	4.8e-05	0.00106	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PKLR—malaria	4.79e-05	0.00105	CbGpPWpGaD
Etodolac—ALB—Metabolism—DHODH—malaria	4.77e-05	0.00105	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—DECR1—malaria	4.72e-05	0.00104	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—HPGDS—malaria	4.69e-05	0.00103	CbGpPWpGaD
Etodolac—RXRA—Metabolism—HPGDS—malaria	4.58e-05	0.00101	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—DHFR—malaria	4.56e-05	0.001	CbGpPWpGaD
Etodolac—PTGS2—Disease—PKLR—malaria	4.54e-05	0.000998	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—SCARB1—malaria	4.51e-05	0.000992	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—SCARB1—malaria	4.31e-05	0.000947	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—G6PD—malaria	4.27e-05	0.000938	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—HBB—malaria	4.26e-05	0.000937	CbGpPWpGaD
Etodolac—RXRA—Metabolism—DHFR—malaria	4.25e-05	0.000935	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—CD36—malaria	4.21e-05	0.000926	CbGpPWpGaD
Etodolac—RXRA—Metabolism—SCARB1—malaria	4.21e-05	0.000925	CbGpPWpGaD
Etodolac—ALB—Metabolism—SLC4A1—malaria	4.06e-05	0.000892	CbGpPWpGaD
Etodolac—PTGS2—Disease—G6PD—malaria	4.05e-05	0.000889	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—HPGDS—malaria	3.99e-05	0.000878	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—IL6—malaria	3.96e-05	0.000872	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—DHODH—malaria	3.91e-05	0.000859	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—IL6—malaria	3.88e-05	0.000852	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.84e-05	0.000845	CbGpPWpGaD
Etodolac—ALB—Metabolism—DECR1—malaria	3.81e-05	0.000839	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PKLR—malaria	3.8e-05	0.000836	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—DHFR—malaria	3.7e-05	0.000814	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—SCARB1—malaria	3.67e-05	0.000806	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—malaria	3.53e-05	0.000775	CbGpPWpGaD
Etodolac—ALB—Metabolism—HBB—malaria	3.45e-05	0.000758	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—G6PD—malaria	3.39e-05	0.000745	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—CD36—malaria	3.34e-05	0.000735	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—CD36—malaria	3.33e-05	0.000732	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SLC4A1—malaria	3.32e-05	0.00073	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malaria	3.27e-05	0.000718	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—HPGDS—malaria	3.25e-05	0.000715	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—IL2—malaria	3.23e-05	0.00071	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—DECR1—malaria	3.12e-05	0.000686	CbGpPWpGaD
Etodolac—ALB—Metabolism—PKLR—malaria	3.07e-05	0.000676	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—DHFR—malaria	3.02e-05	0.000664	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—SCARB1—malaria	2.99e-05	0.000657	CbGpPWpGaD
Etodolac—ALB—Hemostasis—CD36—malaria	2.97e-05	0.000653	CbGpPWpGaD
Etodolac—PTGS2—Disease—DHFR—malaria	2.86e-05	0.000629	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CD36—malaria	2.83e-05	0.000622	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—HBB—malaria	2.82e-05	0.000621	CbGpPWpGaD
Etodolac—ALB—Metabolism—G6PD—malaria	2.74e-05	0.000603	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TNF—malaria	2.71e-05	0.000596	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CD36—malaria	2.7e-05	0.000595	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CD36—malaria	2.64e-05	0.00058	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—HPGDS—malaria	2.58e-05	0.000568	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PKLR—malaria	2.52e-05	0.000553	CbGpPWpGaD
Etodolac—ALB—Hemostasis—NOS2—malaria	2.44e-05	0.000537	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—DHFR—malaria	2.4e-05	0.000527	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—SCARB1—malaria	2.37e-05	0.000521	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CD36—malaria	2.3e-05	0.000506	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—G6PD—malaria	2.24e-05	0.000493	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CD36—malaria	2.21e-05	0.000487	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—IL6—malaria	2.19e-05	0.000481	CbGpPWpGaD
Etodolac—ALB—Metabolism—HPGDS—malaria	2.09e-05	0.00046	CbGpPWpGaD
Etodolac—ALB—Metabolism—DHFR—malaria	1.94e-05	0.000426	CbGpPWpGaD
Etodolac—ALB—Metabolism—SCARB1—malaria	1.92e-05	0.000422	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CD36—malaria	1.88e-05	0.000412	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—HPGDS—malaria	1.71e-05	0.000376	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IL2—malaria	1.66e-05	0.000366	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—DHFR—malaria	1.59e-05	0.000349	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SCARB1—malaria	1.57e-05	0.000345	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CD36—malaria	1.49e-05	0.000327	CbGpPWpGaD
Etodolac—PTGS2—Disease—NOS2—malaria	1.46e-05	0.000321	CbGpPWpGaD
Etodolac—ALB—Metabolism—CD36—malaria	1.2e-05	0.000265	CbGpPWpGaD
Etodolac—PTGS2—Disease—CD4—malaria	1.08e-05	0.000238	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CD36—malaria	9.86e-06	0.000217	CbGpPWpGaD
Etodolac—PTGS2—Disease—IL6—malaria	5.85e-06	0.000129	CbGpPWpGaD
